Every Form 4 that Codexis, Inc. (CDXS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CDXS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDXS filings page.
CODEXIS, INC. director Parker H. Stewart reported receiving a stock option award for 66,350 shares of common stock. The option has an exercise price of $2.48 per share and expires on June 17, 2036, with 66,350 derivative securities held after the grant.
According to the terms, the option vests and becomes exercisable for all 66,350 shares on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to his continued service as a director on that vesting date.
CODEXIS, INC. director Cynthia Collins received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share. The options vest in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, and expire in 2036.
CODEXIS, INC. director Christos Richards received a grant of stock options covering 66,350 shares of common stock at an exercise price of $2.48 per share. The options were awarded at no cost, vesting in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to his continued board service, and will expire on June 17, 2036.
CODEXIS, INC. director David V. Smith received a grant of stock options covering 66,350 shares of common stock. The options have an exercise price of $2.48 per share and expire on June 17, 2036.
According to the footnote, the award vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as Smith continues serving as a director through that vesting date. After this grant, his reported option holdings from this award total 66,350 shares.
CODEXIS, INC. director Rahul Singhvi was granted a stock option covering 66,350 shares of common stock. The option has an exercise price of $2.48 per share and expires on June 17, 2036.
The award vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, as long as he continues serving as a director on that vesting date. Following this grant, his option holdings from this award total 66,350 shares.
CODEXIS, INC. director Esther Martinborough reported receiving a stock option grant covering 66,350 shares of common stock at an exercise price of $2.48 per share. The option vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to her continued board service, and expires on June 17, 2036. Following this grant, she holds options for 66,350 shares directly.
CODEXIS, INC. director Stephen George Dilly reported receiving a grant of stock options. The award covers 66,350 options to buy Common Stock at an exercise price of $2.48 per share, with 66,350 derivative securities shown as held after the transaction.
These options were granted as compensation, not bought on the open market, and carry no upfront cost to the director. They vest and become exercisable for all shares on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, provided he continues serving as a director through that vesting date.
CODEXIS, INC. director Raymond De Vre received a grant of stock options covering 66,350 shares of common stock. The options have an exercise price of $2.48 per share and expire on June 17, 2036. The award vests in full on the earlier of the first anniversary of the grant date or the next annual stockholder meeting, subject to his continued service as a director. Following this grant, De Vre holds 66,350 stock options directly.
CODEXIS, INC. director Raymond De Vre reported an open-market sale of common stock primarily to cover taxes from recently vested equity awards. He sold 2,605 shares at $2.37 per share on June 11, 2026. After this transaction, he holds 84,811 shares directly, including 31,897 Restricted Stock Units, so he retains a substantial continuing stake in the company.
CODEXIS, INC. Chief Scientific Officer Stefan Lutz reported two transactions involving company securities. On February 24, 2026, he sold 5,862 shares of common stock at $1.1329 per share to satisfy tax and other withholding obligations related to vesting Restricted Stock Units, leaving him with 130,421 common shares, which include 23,299 RSUs. On February 23, 2026, he also received a grant of 316,100 stock options with an exercise price of $0.00, vesting 25% on the first anniversary of the grant date and the remaining shares in equal monthly installments over the following three years, subject to his continued employment.
MOORE ALISON reported acquisition or exercise transactions in this Form 4 filing.
CODEXIS, INC. President and CEO Alison Moore reported receiving a stock option award covering 993,000 shares of the company’s stock. The award was granted as a derivative security with no cash purchase on the grant date.
According to the terms, the option vests over four years: 25% of the shares vest on the first anniversary of the grant date, and 1/48th of the original 993,000 shares vests on each monthly anniversary thereafter. Vesting is conditioned on Dr. Moore’s continued employment through the applicable vesting dates.
Erbez Georgia reported acquisition or exercise transactions in this Form 4 filing.
Codexis, Inc. reported that officer Georgia Erbez was granted a stock option covering 316,100 shares of common stock. The option was awarded at a reported price of $0.00 per share, consistent with an equity compensation grant rather than an open-market purchase.
According to the vesting terms, the option becomes exercisable as to 25% of the shares on the first anniversary of the grant date, then as to 1/48 of the original total on each monthly anniversary thereafter. Vesting is conditioned on Erbez’s continued employment through the applicable vesting dates.
Codexis, Inc. Chief Scientific Officer Stefan Lutz reported a small share sale tied to tax withholding. On February 6, 2026, he sold 2,492 shares of common stock at $1.3071 per share, solely to cover tax or other government withholding obligations from vesting restricted stock units.
After this transaction, Lutz beneficially owned 136,283 shares of Codexis common stock, which includes 35,799 restricted stock units. The filing shows he holds the shares directly.
Codexis, Inc. insider Georgia Erbez, the company’s Chief Financial Officer and Chief Business Officer, reported a sale of common stock tied to equity compensation. On February 6, 2026, Erbez sold 3,826 shares of Codexis common stock at $1.3071 per share, solely to cover tax or other government withholding obligations arising from the vesting of restricted stock units.
Following this transaction, Erbez beneficially owned 66,810 shares of Codexis common stock, which includes 24,374 restricted stock units. The filing indicates the holdings are owned directly rather than through an intermediary entity.
Codexis, Inc. President and CEO Alison Moore, who also serves as a director, reported selling 3,826 shares of Codexis common stock on February 6, 2026 at a price of $1.3071 per share. The filing explains that these shares were sold solely to cover tax or other government withholding obligations related to the vesting of restricted stock units.
After this transaction, Moore beneficially owned 250,506 shares of Codexis common stock, which includes 136,249 restricted stock units. The ownership is reported as held directly in her name.
Codexis, Inc. CSO Stefan Lutz reported selling 4,685 shares of Codexis common stock on January 7, 2026 at a price of $1.6968 per share. According to the disclosure, this sale was made to cover tax liabilities arising from the vesting and release of restricted stock units held by him. After this transaction, Lutz beneficially owned 138,775 shares of Codexis common stock, which includes 41,633 restricted stock units, all held directly.
Opaleye Management Inc. filed an amended insider transaction report for its holdings in Codexis, Inc. This Form 4/A corrects a clerical error for a November 26, 2025 trade that was originally reported as a stock acquisition and is now correctly shown as a disposition of Codexis common shares.
The report lists multiple indirect sales of Codexis common stock, par value $0.001 per share, through Opaleye, L.P. and a separately managed account on November 26, November 28 and December 1, 2025. Share blocks were sold at weighted average prices of $1.7413, $1.75 and $1.6675 per share, with actual trade prices within ranges of $1.7316–$1.75699, $1.73–$1.7715 and $1.65–$1.7101 as described in the footnotes. After the December 1, 2025 transactions, the report shows 9,955,000 Codexis shares indirectly held via Opaleye, L.P. and 179,989 shares via a managed account.
Codexis, Inc. director-affiliated investor Opaleye Management Inc. filed an amended ownership report detailing recent sales of Codexis common stock made through affiliated investment vehicles.
On 11/07/2025, Opaleye L.P. sold 296,682 shares and a separately managed account sold 10,000 shares, each at a weighted average price of $1.6968 per share. Additional sales occurred on 11/10/2025 of 205,000 and 3,318 shares at a weighted average price of $1.7347, and on 11/11/2025 of 535,000 and 13,211 shares at a weighted average price of $1.7994.
Following these transactions, Opaleye L.P. is reported as indirectly holding 11,508,318 shares, and the managed account 223,461 shares of Codexis common stock. The amendment corrects a clerical error so that the 11/07/2025 trades are properly coded as dispositions rather than acquisitions, with no other changes.
Codexis, Inc. (CDXS) reported an insider transaction by a director on a Form 4. On 11/21/2025, the reporting person sold 8,952 shares of common stock in an open-market transaction coded as "S" (sale).
The weighted average sale price was $1.5626 per share, with individual trades executed between $1.55 and $1.615. Following this sale, the reporting person beneficially owns 138,951 shares, held directly, which includes 40,983 restricted stock units.
Codexis, Inc. (CDXS) reported an equity award to its President and CEO, Alison Moore, on Form 4. On 11/13/2025 she received 85,000 shares of common stock in the form of restricted stock units, at a stated price of $0. These units vest in three equal annual installments on each anniversary of the grant date, provided she remains employed.
On the same date she was also granted a stock option for 500,000 shares of common stock at an exercise price of $1.63 per share, expiring on 11/13/2035. The option vests as to 25% of the shares on the first anniversary of the grant date and 1/48th of the original total each month thereafter, conditioned on continued employment. Following these transactions, she beneficially owns 254,332 shares, including 145,208 restricted stock units.
Codexis (CDXS): Opaleye Management Inc., as reporting person, disclosed open‑market sales of Codexis common stock on 11/12/2025. Transactions included 890,000 shares at $1.9372 and 165,000 shares at $1.962 through Opaleye, L.P., plus 27,459 shares at $1.9372 via a separately managed account. The prices are weighted averages; the shares were sold in multiple trades within disclosed ranges.
Following the reported transactions, beneficial ownership reported as indirect included 10,453,318 shares by Opaleye, L.P. and 196,012 shares by the managed account. The pricing footnotes state sales occurred across ranges of $1.9005–$1.9905 and $1.935–$2.0035, with full trade details available upon request.
Codexis (CDXS) reported a Form 4 for director Raymond De Vre. On 11/11/2025, he sold 1,413 shares of common stock at $1.74 per share, coded “S.” The filing notes the sale was effected to cover tax liability from the vesting and release of restricted stock units. After the transaction, he beneficially owned 87,416 shares, which includes 72,880 restricted stock units. Ownership is reported as direct.
Codexis, Inc. (CDXS) reported an insider open‑market purchase. Director Stephen G. Dilly bought 50,000 shares of common stock on 11/11/2025 at a weighted average price of $1.8473, executed in multiple trades ranging from $1.7550 to $1.90.
After this transaction, he beneficially owns 727,053 shares, held directly. This total includes 2,000 shares acquired under the Employee Stock Purchase Plan on May 10, 2025 and 2,000 shares acquired on Nov 10, 2025.
Opaleye Management Inc., a director of Codexis (CDXS), reported open‑market sales of common stock. Transactions occurred on 11/07/2025, 11/10/2025, and 11/11/2025 at weighted average prices of $1.6968, $1.7347, and $1.7994, respectively.
Reported sale sizes included 296,682 and 10,000 shares on 11/07/2025; 205,000 and 3,318 shares on 11/10/2025; and 535,000 and 13,211 shares on 11/11/2025. Following these transactions, beneficial ownership was 11,508,318 shares indirectly through Opaleye, L.P., and 223,461 shares indirectly through a managed account.
Codexis (CDXS) reported an insider transaction by its Chief Financial Officer, Georgia Erbez. On 10/13/2025, she sold 6,239 shares of common stock at $2.505 per share. The filing notes the sale was made solely to satisfy tax or other government withholding obligations tied to the vesting of Restricted Stock Units.
Following the transaction, Erbez beneficially owned 70,636 shares directly, which includes 33,333 RSUs. The transaction code was listed as S, indicating a sale.
Codexis (CDXS) filed a Form 4 reporting that Chief Technical Officer Alison Moore sold 6,239 shares of common stock on 10/13/2025 at $2.5051 per share. The filing states the sale was made solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units.
Following the transaction, Alison Moore beneficially owns 169,332 shares, which includes 33,333 restricted stock units. Ownership is reported as direct, and the filing was made by one reporting person.